Bausch Health Companies (BHC) Revenue (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Revenue data on file, last reported at $2.5 billion in Q1 2026.

• Quarterly Revenue rose 11.73% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 8.22% YoY) and the FY2025 annual result came in at $10.3 billion, up 6.66% from the prior year.
• Revenue fell to $2.5 billion in Q1 2026 per BHC's latest filing, from $2.8 billion in the prior quarter.
• The five-year high for Revenue was $2.8 billion in Q4 2025, with the low at $1.9 billion in Q1 2022.
• Average Revenue over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2025.
• Year-over-year, Revenue slumped 69.71% in 2022 and advanced 12.15% in 2024.
• Bausch Health Companies' Revenue stood at $2.2 billion in 2022, then advanced by 9.8% to $2.4 billion in 2023, then advanced by 6.27% to $2.6 billion in 2024, then gained by 9.26% to $2.8 billion in 2025, then fell by 9.73% to $2.5 billion in 2026.
• Business Quant data shows BHC's Revenue at $2.5 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.7 billion in Q3 2025.